{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/haematological-cancers-recognition-referral/diagnosis/investigations-in-primary-care/","result":{"pageContext":{"chapter":{"id":"129bfa10-e11b-5bf8-aeac-2ec5de9171d7","slug":"investigations-in-primary-care","fullItemName":"Investigations in primary care","depth":2,"htmlHeader":"<!-- begin field 84a62ebf-ee6c-40d7-adfc-6624ce79dbc1 --><h2>Investigations in primary care</h2><!-- end field 84a62ebf-ee6c-40d7-adfc-6624ce79dbc1 -->","summary":"","htmlStringContent":"<!-- begin item 628cde8c-8ef7-41a4-9e9d-270216a4fd59 --><!-- begin field 2e631074-203e-49ce-86e5-49d24955b8e9 --><p><strong>Table 3</strong><strong>. </strong>Investigations in primary care.</p><table data-table-id=\"37f99aa0-d7ff-4ec5-8fe4-acce014f1688\"><thead><tr><th colspan=\"1\"><p>Symptom</p></th><th colspan=\"1\"><p>Possible cancer</p></th><th colspan=\"1\"><p>Referral recommendation</p></th></tr></thead><tbody><tr><td colspan=\"1\">Hypercalcaemia or leukopenia and presentation consistent with possible myeloma, 60 years and over</td><td colspan=\"1\">Myeloma</td><td colspan=\"1\">Offer very urgent protein electrophoresis and a Bence-Jones protein urine test (within 48 hours)</td></tr><tr><td colspan=\"1\">Plasma viscosity or erythrocyte sedimentation rate and presentation consistent with possible myeloma</td><td colspan=\"1\">Myeloma</td><td colspan=\"1\">Consider very urgent protein electrophoresis and a Bence-Jones protein urine test (within 48 hours)</td></tr><tr><td colspan=\"1\">Protein electrophoresis suggests myeloma</td><td colspan=\"1\">Myeloma</td><td colspan=\"1\">Refer people using a suspected cancer pathway referral (for an appointment within 2 weeks)</td></tr><tr><td colspan=\"1\">Bence-Jones protein urine results suggest myeloma</td><td colspan=\"1\">Myeloma</td><td colspan=\"1\">Refer people using a suspected cancer pathway referral (for an appointment within 2 weeks)</td></tr><tr><td colspan=\"3\"><strong>Data from:</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/haematological-cancers-recognition-referral/references/\">NICE, 2015</a>]</td></tr></tbody></table><!-- end field 2e631074-203e-49ce-86e5-49d24955b8e9 --><!-- end item 628cde8c-8ef7-41a4-9e9d-270216a4fd59 -->","topic":{"id":"7a666688-628e-59c5-9e49-275e6df96c89","topicId":"efd78d5c-f39b-47aa-a99a-712fcd440511","topicName":"Haematological cancers - recognition and referral","slug":"haematological-cancers-recognition-referral","lastRevised":"Last revised in February 2021","chapters":[{"id":"1b99cc60-959f-5937-a54d-248dd557eb06","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"f3b3ad5d-37b7-5a29-8e71-51338dfd53d0","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"77a57871-2fdc-584c-9148-924a40f28c72","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"1b4978ef-a636-510a-b98b-df2c1d638607","slug":"changes","fullItemName":"Changes"},{"id":"31156ad7-e1ac-50f7-a238-d5ab91d07500","slug":"update","fullItemName":"Update"}]},{"id":"dfef533d-7728-5775-8f82-3e745c90c505","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"388024d8-7d15-587b-8988-d7c628863b80","slug":"goals","fullItemName":"Goals"},{"id":"c513e6cc-f297-57a6-adef-8b1e4f1f8f2c","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"7e3cb3e7-e51c-5962-8394-f4e0a6813935","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"3aaac357-49bc-50e7-9bc7-f68a75f8f23b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"f422ee8f-401a-55f0-af2e-ec46fece5aba","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"7a906314-79dc-5a14-86d9-f6c963dbfaf0","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0205c796-921c-5df9-aa6e-52892106204f","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"0075cdde-2c8e-5e7d-9734-e640651b657b","slug":"presentation","fullItemName":"Presentation"},{"id":"76cd470e-5904-5537-8ec0-73d5a2425747","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0fbae03d-8109-54c7-ad40-6ad26a3ae1b4","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"f824311f-b5dd-585e-bda3-3f418f0cd768","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"399985ab-242f-53f8-8852-45b946548d09","slug":"symptoms-suggestive-of-haematological-cancers","fullItemName":"Symptoms suggestive of haematological cancers"},{"id":"129bfa10-e11b-5bf8-aeac-2ec5de9171d7","slug":"investigations-in-primary-care","fullItemName":"Investigations in primary care"}]},{"id":"e4e9d509-0950-59c5-9f10-397475616fe8","fullItemName":"Management","slug":"management","subChapters":[{"id":"cfe47d3f-300b-5be4-b4da-3dd966fef722","slug":"referral-for-haematological-cancer","fullItemName":"Scenario: Referral for haematological cancer"}]},{"id":"61fcee5d-ff66-5a4c-91e7-4f497dfcc559","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"ae7d0bdc-fc33-577f-9cfe-009a08676afa","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"f9e3a44b-54f7-5761-b0f1-43617129d77e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"13a9be84-5d20-5ab3-8ea3-6490e30776d4","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"e1c7b25a-a475-5f05-a2da-9d859d501051","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f9ed371b-e3f7-510a-a3f5-e7c55990b468","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"ff05ddf2-8028-5120-8912-94378fd8dc5a","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"f7896863-2653-51f8-8deb-f8525add21d6","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"f824311f-b5dd-585e-bda3-3f418f0cd768","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"6e7f4fef-292f-5265-be83-88b12908ac11","slug":"basis-for-recommendation-97f","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 42284401-e6fe-4c82-b382-e8eb849ae637 --><h3>Basis for recommendation</h3><!-- end field 42284401-e6fe-4c82-b382-e8eb849ae637 -->","summary":null,"htmlStringContent":"<!-- begin item 97f4fa41-6330-4818-9404-b249bcc46c7c --><!-- begin field 43c8e35b-efbc-4021-a8d0-9ed4a7ebcab6 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/haematological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 43c8e35b-efbc-4021-a8d0-9ed4a7ebcab6 --><!-- end item 97f4fa41-6330-4818-9404-b249bcc46c7c -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}